Wuhan Jianmin Pharmaceutical Group Co., Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Wuhan Jianmin Pharmaceutical Group Co., Ltd. with three other
companies in this sector in China:
Pengqi Technology Development Co Ltd
sales of 2.33 billion Chinese Renmimbi [US$351.00 million]
of which 83%
Zhangzhou Pientzehuang Pharmaceutical Ltd
(2.31 billion Chinese Renmimbi [US$348.38 million]
of which 48%
was Pharmaceutical Manufacturing), and
Heilongjiang ZBD Pharmaceutical Co Ltd
(2.39 billion Chinese Renmimbi [US$360.88 million]
of which 79%
was Pharmaceutical Industry).
Wuhan Jianmin Pharmaceutical Group Co., Ltd. reported sales of 2.36 billion Chinese Renmimbi (US$356.66 million)
December of 2016.
increase of 3.6%
versus 2015, when the company's sales were 2.28 billion Chinese Renmimbi.
Sales of Pharmaceutical saw an increase
that was more than double the company's growth rate: sales were up
28.1% in 2016, from
668.29 million Chinese Renmimbi to 855.80 million Chinese Renmimbi.